Clinical competency
Trauma treatment background
Therapists need a solid professional background in psychotherapy, especially PTSD treatment. Prior experience with established trauma therapies and related approaches is considered important preparation for this work.
Looking for something specific? Ask Blossom
Guidelines
3
Courses
0
Providers
0
Protocols
1
Classification
Competency categories
Care stages
Roles
Protocol families
Source quality
Across the manuals
The manuals converge on the view that trauma treatment background is a core requirement for MDMA-assisted psychotherapy. Across the extracts, the therapist is expected to have a solid professional background in psychotherapy, with particular importance placed on PTSD treatment and on prior experience with established trauma therapies. The sources also agree that this work is not limited to a narrow symptom focus, but involves understanding complex trauma presentations and working with trauma-related vulnerability in a supportive, trauma-informed way. The manuals also overlap in naming PTSD complexity as central. They refer to severe PTSD, chronic or complex trauma histories, dissociative presentations, and common comorbidities such as depression and substance use risk. They further indicate that prior training in approaches such as Prolonged Exposure, Cognitive Processing Therapy, EMDR, and psychodynamic psychotherapy is relevant preparation, and that broader trauma-related or integrative approaches may also be helpful. The main differences are in emphasis and specificity. One manual gives a broader training map, listing a wide range of potentially helpful modalities and noting that strictly behavioural or cognitive-behavioural approaches alone may be limiting unless balanced by other approaches.
Synthesised from the linked source documents; refreshed as the library updates.
Linked sources
The guidelines, courses, and providers that evidence this competency. Full lists are a Blossom Pro feature.
Linked guidelines (3)
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial
MDMAEvidence score: 90
Unlock every linked source
See all linked guidelines, courses, and providers behind this competency, plus the full competency graph.